Author Archives: Jason Carr
Cowen & Co. Maintains a Buy Rating on Kura Oncology (KURA)
Cowen & Co. analyst Chris Shibutani maintained a Buy rating on Kura Oncology (KURA – Research Report) today. The company’s shares opened today at $18.91. According to TipRanks.com, Shibutani is a 3-star analyst with an average return of 2.0% and
Raymond James Reaffirms Their Hold Rating on Stantec (STN)
The Materials sector company, Stantec (STN – Research Report), has received a rating update from a Wall Street analyst today. Analyst Ben Cherniavsky from Raymond James remains neutral on the stock and has a C$35 price target. According to TipRanks.com,
Rattler Midstream LP (RTLR) Gets a Buy Rating from Northland Securities
Northland Securities analyst Jeff Grampp maintained a Buy rating on Rattler Midstream LP (RTLR – Research Report) today and set a price target of $24. The company’s shares closed on Friday at $19.21. Grampp said: “We are initiating on Rattler
Raymond James Keeps a Buy Rating on Dollarama (DOL)
The Services sector company, Dollarama (DOL – Research Report), has received a rating update from a Wall Street analyst today. Analyst Kenric Tyghe from Raymond James reiterated a Buy rating, with a C$48 price target. According to TipRanks.com, Tyghe is
Analysts Offer Insights on Healthcare Companies: Nektar Therapeutics (NASDAQ: NKTR), Kezar Life Sciences Inc (NASDAQ: KZR) and Lemaitre Vascular (NASDAQ: LMAT)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Nektar Therapeutics (NKTR – Research Report), Kezar Life Sciences Inc (KZR – Research Report) and Lemaitre Vascular (LMAT – Research Report) with
Analysts Offer Insights on Healthcare Companies: Esperion (NASDAQ: ESPR) and Kezar Life Sciences Inc (NASDAQ: KZR)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Esperion (ESPR – Research Report) and Kezar Life Sciences Inc (KZR – Research Report) with bullish sentiments. Esperion (ESPR) In a report
